In this study, we found first a reduced levels of TYRO3 in circulating monocytes, dendritic cells, and CD4 lymphocytes in patients with only MS, compared to healthy donors, denoting a strong influence of the disease condition. This evidence concerns the gene TYRO3 and myeloid sarcoma.